The pain management platform developer has now raised at least $125m altogether, after pulling in series C funding from investors including Optum.
Kaia Health, the US-based developer of a chronic pain management platform, has received $75m in a series C round featuring Optum Ventures, the corporate venture capital arm of healthcare services provider Optum, TechCrunch reported on Wednesday.
The round was led by an undisclosed growth equity fund and it also featured Eurazeo, 3VC, Balderton Capital, Heartcore Capital, Symphony and A Round Capital.
Founded in 2016, Kaia operates a digital platform whichprovides physical exercise insructions and mind and body relaxation techniques for…
